SCHEMBL5747459

SCHEMBL5747459

CC(=O)NC(Cc1c[nH]c2ccccc12)C(C)=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 6/20 0.67
ALOX15 P16050 1/20 0.65
ACE P12821 3/20 0.60
BCL2A1 Q16548 2/20 0.60
KMT2A Q03164 2/20 0.60
KDM4E B2RXH2 2/20 0.60
POLB P06746 2/20 0.60
MAPT P10636 2/20 0.60
MEN1 O00255 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.60
TP53 P04637 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
NFKB1 P19838 1/20 0.60
APEX1 P27695 1/20 0.60
CYP2C19 P33261 1/20 0.60
THPO P40225 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13176572 1.00 TACR1 (0.67) TACR1ALOX15ACEBCL2A1KMT2A
Acetyltryptophanamide SCHEMBL455277 0.92 ECE1 (0.68) TACR1ALOX15ACEBCL2A1KMT2A
Acetyltryptophanamide SCHEMBL3202823 0.92 ECE1 (0.68) TACR1ALOX15ACEBCL2A1KMT2A
Acetyltryptophanamide SCHEMBL22850012 0.92 ECE1 (0.68) TACR1ALOX15ACEBCL2A1KMT2A
Acetyltryptophan SCHEMBL57140 0.90 ALOX15 (0.79) TACR1ALOX15ACEKDM4EPOLB
Acetyltryptophan SCHEMBL29360698 0.90 ALOX15 (0.79) TACR1ALOX15ACEKDM4EPOLB
Acetyltryptophan SCHEMBL57141 0.90 ALOX15 (0.79) TACR1ALOX15ACEKDM4EPOLB
Acetyltryptophan SCHEMBL29401158 0.90 ALOX15 (0.79) TACR1ALOX15ACEKDM4EPOLB
Acetyltryptophan SCHEMBL702442 0.90 ALOX15 (0.79) TACR1ALOX15ACEKDM4EPOLB
Acetyltryptophan SCHEMBL4216450 0.90 ALOX15 (0.79) TACR1ALOX15ACEKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9630989-B2 Dipeptide analogs for treating conditions associated with amyloid fibril formation RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2017-04-25 US disclosed
US-9630989-B2 Dipeptide analogs for treating conditions associated with amyloid fibril formation RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2017-04-25 US disclosed
US-9096645-B2 Dipeptide analogs for treating conditions associated with amyloid fibril formation RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2015-08-04 US disclosed
US-9096645-B2 Dipeptide analogs for treating conditions associated with amyloid fibril formation RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2015-08-04 US disclosed
EP-0842923-B1 PYRROLE DERIVATIVES AND MEDICINAL COMPOSITION NIPPON SHINYAKU CO LTD (JP) 2006-03-01 EP disclosed
CN-1090617-C Pyrrole derivatives and pharmaceutical compositions NIPPON SHINYAKU CO LTD (JP) 2002-09-11 CN disclosed
CN-1349796-A Pyrrole derivatives and medicine composition NIPPON SHINYAKU CO LTD (JP) 2002-05-22 CN disclosed
US-6172102-B1 POLLAKIURIA OR URINARY INCONTINENCE NIPPON SHINYAKU CO., LTD. (JP) 2001-01-09 US disclosed
US-5998459-A INCOTINENCE THERAPY NIPPON SHINYAKU CO., LTD. (JP) 1999-12-07 US disclosed
CN-1186485-A Pyrrole derivatives and pharmaceutical compositions NIPPON SHINYAKU CO LTD (JP) 1998-07-01 CN disclosed
EP-0842923-A1 PYRROLE DERIVATIVES AND MEDICINAL COMPOSITION NIPPON SHINYAKU COMPANY, LIMITED (JP) 1998-05-20 EP disclosed